Boldenone: Difference between revisions
No edit summary |
Innerstream (talk | contribs) mNo edit summary |
||
(27 intermediate revisions by 22 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{Distinguish|1-Testosterone}} |
{{Distinguish|1-Testosterone}} |
||
{{Drugbox |
{{Drugbox |
||
Line 5: | Line 6: | ||
| verifiedrevid = 447429808 |
| verifiedrevid = 447429808 |
||
| IUPAC_name = (8''R'',9''S'',10''R'',13''S'',14''S'',17''S'')-17-Hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3''H''-cyclopenta[''a'']phenanthren-3-one |
| IUPAC_name = (8''R'',9''S'',10''R'',13''S'',14''S'',17''S'')-17-Hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3''H''-cyclopenta[''a'']phenanthren-3-one |
||
| image = Boldenone. |
| image = Boldenone.svg |
||
| width = |
| width = 215px |
||
| image2 = Boldenone molecule ball.png |
|||
| width2 = 225px |
|||
<!--Clinical data--> |
<!--Clinical data--> |
||
Line 12: | Line 15: | ||
| Drugs.com = {{Drugs.com|international|boldenone}} |
| Drugs.com = {{Drugs.com|international|boldenone}} |
||
| pregnancy_category = X ([[United States|US]])<br />X ([[Australia|AUS]]) |
| pregnancy_category = X ([[United States|US]])<br />X ([[Australia|AUS]]) |
||
| legal_BR = C5 |
|||
| legal_BR_comment = <ref>{{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-03-31 |title=RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |url-status=live |archive-url=https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |archive-date=2023-08-03 |access-date=2023-08-15 |publisher=[[Diário Oficial da União]] |language=pt-BR |publication-date=2023-04-04}}</ref> |
|||
| legal_CA = Schedule IV |
| legal_CA = Schedule IV |
||
| legal_US = Schedule III |
| legal_US = Schedule III |
||
Line 23: | Line 28: | ||
| protein_bound = |
| protein_bound = |
||
| metabolism = |
| metabolism = |
||
| elimination_half-life = [[Intramuscular injection|Intramuscular]]: 14 days (as [[boldenone undecylenate]]){{ |
| elimination_half-life = [[Intramuscular injection|Intramuscular]]: 14 days (as [[boldenone undecylenate]])<ref name="RuizStrain2011">{{cite book| vauthors = Ruiz P, Strain EC |title=Lowinson and Ruiz's Substance Abuse: A Comprehensive Textbook|url=https://books.google.com/books?id=w4ZUJAdleTsC&pg=PA358|year=2011|publisher=Lippincott Williams & Wilkins|isbn=978-1-60547-277-5|pages=358–}}</ref> |
||
| excretion = |
| excretion = |
||
Line 46: | Line 51: | ||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=19 | H=26 | O=2 |
| C=19 | H=26 | O=2 |
||
| molecular_weight = 286.409 g/mol |
|||
| SMILES = O=C\1\C=C/[C@]4(/C(=C/1)CC[C@@H]2[C@@H]4CC[C@@]3([C@@H](O)CC[C@@H]23)C)C |
| SMILES = O=C\1\C=C/[C@]4(/C(=C/1)CC[C@@H]2[C@@H]4CC[C@@]3([C@@H](O)CC[C@@H]23)C)C |
||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
Line 57: | Line 61: | ||
}} |
}} |
||
'''Boldenone''' |
'''Boldenone''' (developmental code name '''RU-18761'''), is a [[natural product|naturally occurring]] [[anabolic–androgenic steroid]] (AAS) and the 1(2)-[[dehydrogenated]] [[structural analog|analogue]] of [[testosterone]].<ref name="Elks2014">{{cite book| vauthors = Elks J |title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA640|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=640–}}</ref><ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA131|year=2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=131–}}</ref><ref name="MortonHall2012">{{cite book| vauthors = Morton IK, Hall JM |title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms |url=https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA52|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-94-011-4439-1|pages=52–}}</ref><ref name="Drugs.com">{{cite web|title=Boldenone international brand names|url=https://www.drugs.com/international/boldenone.html|publisher=Drugs.com|access-date=28 April 2017}}</ref><ref name="Llewellyn2011">{{cite book| vauthors = Llewellyn W |title=Anabolics |url= https://books.google.com/books?id=afKLA-6wW0oC&pg=PT483 |year=2011 |publisher=Molecular Nutrition Llc |isbn=978-0-9828280-1-4 |pages=483–490}}</ref> Boldenone itself has never been marketed; as a [[pharmaceutical drug]], it is used as [[boldenone undecylenate]], the [[undecylic acid|undecylenate]] [[ester]].<ref name="Elks2014" /><ref name="IndexNominum2000" /><ref name="Llewellyn2011" /> |
||
{{TOC limit|3}} |
{{TOC limit|3}} |
||
Line 67: | Line 71: | ||
===Pharmacodynamics=== |
===Pharmacodynamics=== |
||
Like other AAS, boldenone is an [[agonist]] of the [[androgen receptor]] (AR).<ref name="Llewellyn2011" /> The activity of boldenone is mainly [[anabolic]], with a low [[androgenic]] potency. Boldenone will increase [[nitrogen]] retention, protein synthesis, increases appetite and stimulates the release of [[erythropoietin]] in the kidneys.<ref>Forbes GB |
Like other AAS, boldenone is an [[agonist]] of the [[androgen receptor]] (AR).<ref name="Llewellyn2011" /> The activity of boldenone is mainly [[anabolic]], with a low [[androgenic]] potency. Boldenone will increase [[nitrogen]] retention, protein synthesis, increases appetite and stimulates the release of [[erythropoietin]] in the kidneys.<ref name="Forbes_1985">{{cite journal | vauthors = Forbes GB | title = The effect of anabolic steroids on lean body mass: the dose response curve | journal = Metabolism: Clinical and Experimental | volume = 34 | issue = 6 | pages = 571–3 | date = June 1985 | pmid = 3999979 | doi = 10.1016/0026-0495(85)90196-9 }}</ref> |
||
==Chemistry== |
==Chemistry== |
||
{{See also|List of androgens/anabolic steroids}} |
{{See also|List of androgens/anabolic steroids}} |
||
Boldenone, also known as Δ<sup>1</sup>-testosterone, 1-dehydrotestosterone, or androsta-1,4-dien-17β-ol-3-one, is a [[natural product|naturally occurring]] [[androstane]] [[steroid]] and a [[chemical derivative|derivative]] of [[testosterone]].<ref name="Elks2014" /><ref name="IndexNominum2000" /><ref name="Llewellyn2011" /> It is specifically testosterone with a [[double bond]] between the C1 and C2 positions.<ref name="Elks2014" /><ref name="IndexNominum2000" /><ref name="Llewellyn2011" /> A related compound is [[quinbolone]], the 17-[[cyclopentene|cyclopentenyl]] [[enol |
Boldenone, also known as Δ<sup>1</sup>-testosterone, 1-dehydrotestosterone, or androsta-1,4-dien-17β-ol-3-one, is a [[natural product|naturally occurring]] [[androstane]] [[steroid]] and a [[chemical derivative|derivative]] of [[testosterone]].<ref name="Elks2014" /><ref name="IndexNominum2000" /><ref name="Llewellyn2011" /> It is specifically testosterone with a [[double bond]] between the C1 and C2 positions.<ref name="Elks2014" /><ref name="IndexNominum2000" /><ref name="Llewellyn2011" /> A related compound is [[quinbolone]], the 17-[[cyclopentene|cyclopentenyl]] [[enol ether]] of boldenone.<ref name="Elks2014" /><ref name="IndexNominum2000" /> |
||
===Sources=== |
===Sources=== |
||
Boldenone occurs naturally in the [[scent gland]] of ''[[Ilybius fenestratus]]'', a species of [[beetle]].<ref name="Elks2014" /> |
Boldenone occurs naturally in the [[scent gland]] of ''[[Ilybius fenestratus]]'', a species of [[aquatic beetle]].<ref name="Elks2014" /> |
||
==History== |
==History== |
||
[[Ciba Specialty Chemicals|Ciba]] reportedly patented boldenone in 1949.<ref name="Llewellyn2011" /> It subsequently developed several experimental esters of the drug in the 1950s and 1960s.<ref name="Llewellyn2011" /> One of these was boldenone undecylenate, which was introduced for clinical use under the brand name Parenabol and saw some use in the late 1960s and early 1970s.<ref name="Llewellyn2011" /> However, it was discontinued before the end of the 1970s.<ref name="Llewellyn2011" /> Subsequently, boldenone undecylenate was introduced by [[Squibb]] under the brand name Equipose for veterinary use most commonly in horses.<ref name="Llewellyn2011" /> |
[[Ciba Specialty Chemicals|Ciba]] reportedly patented boldenone in 1949.<ref name="Llewellyn2011" /> It subsequently developed several experimental esters of the drug in the 1950s and 1960s.<ref name="Llewellyn2011" /> One of these was boldenone undecylenate, which was introduced for clinical use under the brand name Parenabol and saw some use in the late 1960s and early 1970s.<ref name="Llewellyn2011" /> However, it was discontinued before the end of the 1970s.<ref name="Llewellyn2011" /> Subsequently, [[boldenone undecylenate]] was introduced by [[Bristol-Myers Squibb|Squibb]] under the brand name Equipose for veterinary use, most commonly in horses.<ref name="Llewellyn2011" /> |
||
==Society and culture== |
==Society and culture== |
||
Line 86: | Line 90: | ||
===Brand names=== |
===Brand names=== |
||
Boldenone is marketed as [[veterinary drug]] as boldenone undecylenate (a derivative of boldenone) under the following brand names: Boldebal H, Equipoise, and Sybolin.<ref name="Drugs.com" /> It is marketed as a veterinary [[combination drug]] with [[methandriol]] under the brand name Drive.<ref name="Drugs.com" /> |
Boldenone is marketed as [[veterinary drug]] as boldenone undecylenate (a derivative of boldenone) under the following brand names: ''Boldebal H'', ''Equipoise'', and ''Sybolin''.<ref name="Drugs.com" /> It is marketed as a veterinary [[combination drug]] with [[methandriol]] under the brand name ''Drive''.<ref name="Drugs.com" /> |
||
In [[Ukraine]], it is marketed for human consumption as the injectable steroid ''Boldenol''.<ref name="boldenol">{{cite web | work = Lyka Labs |title=Boldenol 200 (boldenone undecylenate) |url=http://ukroids.club/index.php?main_page=product_info&products_id=5071 |access-date=15 January 2020}}</ref> |
|||
===Doping in sports=== |
===Doping in sports=== |
||
Line 97: | Line 103: | ||
==External links== |
==External links== |
||
* [https://anabolic.org/equipoise-boldenone-undecylenate/ Equipoise (boldenone undecylenate) - William Llewellyn's Anabolic.org] |
* [https://web.archive.org/web/20190629101049/https://anabolic.org/equipoise-boldenone-undecylenate/ Equipoise (boldenone undecylenate) - William Llewellyn's Anabolic.org] |
||
{{Androgens and antiandrogens}} |
{{Androgens and antiandrogens}} |
||
{{Androgen receptor modulators}} |
{{Androgen receptor modulators}} |
||
[[Category: |
[[Category:Secondary alcohols]] |
||
[[Category: |
[[Category:Anabolic–androgenic steroids]] |
||
[[Category:Androstanes]] |
[[Category:Androstanes]] |
||
[[Category: |
[[Category:Conjugated dienes]] |
||
[[Category:Drugs in sport]] |
[[Category:Drugs in sport]] |
||
[[Category:Equine medications]] |
[[Category:Equine medications]] |
||
[[Category: |
[[Category:Enones]] |
||
[[Category:World Anti-Doping Agency prohibited substances]] |
Latest revision as of 12:33, 26 October 2024
Clinical data | |
---|---|
Other names | Δ1-Testosterone; 1-Dehydrotestosterone; RU-18761; Androsta-1,4-dien-17β-ol-3-one |
AHFS/Drugs.com | International Drug Names |
Pregnancy category | |
Routes of administration | Intramuscular injection |
Drug class | Androgen; Anabolic steroid |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | Intramuscular: 14 days (as boldenone undecylenate)[2] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.011.533 |
Chemical and physical data | |
Formula | C19H26O2 |
Molar mass | 286.415 g·mol−1 |
3D model (JSmol) | |
Melting point | 165 °C (329 °F) |
| |
| |
(what is this?) (verify) |
Boldenone (developmental code name RU-18761), is a naturally occurring anabolic–androgenic steroid (AAS) and the 1(2)-dehydrogenated analogue of testosterone.[3][4][5][6][7] Boldenone itself has never been marketed; as a pharmaceutical drug, it is used as boldenone undecylenate, the undecylenate ester.[3][4][7]
Side effects
[edit]Pharmacology
[edit]Pharmacodynamics
[edit]Like other AAS, boldenone is an agonist of the androgen receptor (AR).[7] The activity of boldenone is mainly anabolic, with a low androgenic potency. Boldenone will increase nitrogen retention, protein synthesis, increases appetite and stimulates the release of erythropoietin in the kidneys.[8]
Chemistry
[edit]Boldenone, also known as Δ1-testosterone, 1-dehydrotestosterone, or androsta-1,4-dien-17β-ol-3-one, is a naturally occurring androstane steroid and a derivative of testosterone.[3][4][7] It is specifically testosterone with a double bond between the C1 and C2 positions.[3][4][7] A related compound is quinbolone, the 17-cyclopentenyl enol ether of boldenone.[3][4]
Sources
[edit]Boldenone occurs naturally in the scent gland of Ilybius fenestratus, a species of aquatic beetle.[3]
History
[edit]Ciba reportedly patented boldenone in 1949.[7] It subsequently developed several experimental esters of the drug in the 1950s and 1960s.[7] One of these was boldenone undecylenate, which was introduced for clinical use under the brand name Parenabol and saw some use in the late 1960s and early 1970s.[7] However, it was discontinued before the end of the 1970s.[7] Subsequently, boldenone undecylenate was introduced by Squibb under the brand name Equipose for veterinary use, most commonly in horses.[7]
Society and culture
[edit]Generic names
[edit]Boldenone is the generic name of the drug and its INN and BAN .[3][4][5][6]
Brand names
[edit]Boldenone is marketed as veterinary drug as boldenone undecylenate (a derivative of boldenone) under the following brand names: Boldebal H, Equipoise, and Sybolin.[6] It is marketed as a veterinary combination drug with methandriol under the brand name Drive.[6]
In Ukraine, it is marketed for human consumption as the injectable steroid Boldenol.[9]
Doping in sports
[edit]There are many known cases of doping in sports with boldenone undecylenate by professional athletes.
References
[edit]- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-15.
- ^ Ruiz P, Strain EC (2011). Lowinson and Ruiz's Substance Abuse: A Comprehensive Textbook. Lippincott Williams & Wilkins. pp. 358–. ISBN 978-1-60547-277-5.
- ^ a b c d e f g Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 640–. ISBN 978-1-4757-2085-3.
- ^ a b c d e f Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 131–. ISBN 978-3-88763-075-1.
- ^ a b Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 52–. ISBN 978-94-011-4439-1.
- ^ a b c d "Boldenone international brand names". Drugs.com. Retrieved 28 April 2017.
- ^ a b c d e f g h i j Llewellyn W (2011). Anabolics. Molecular Nutrition Llc. pp. 483–490. ISBN 978-0-9828280-1-4.
- ^ Forbes GB (June 1985). "The effect of anabolic steroids on lean body mass: the dose response curve". Metabolism: Clinical and Experimental. 34 (6): 571–3. doi:10.1016/0026-0495(85)90196-9. PMID 3999979.
- ^ "Boldenol 200 (boldenone undecylenate)". Lyka Labs. Retrieved 15 January 2020.